My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Exponent, Inc. - Common Stock (NQ:EXPO)

73.08 -0.66 (-0.89%)

Streaming Delayed Price Updated: 1:44 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Exponent, Inc. - Common Stock

< Previous 1 2 3 Next >

1 Cash-Heavy Stock Worth Your Attention and 2 Facing Challenges

January 01, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Why Exponent (EXPO) Stock Is Trading Up Today

December 15, 2025

Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped in the afternoon session after UBS raised its price target on the company's stock to $81 from $76. The financial services firm kept a...

Via StockStory

Q3 Rundown: Exponent (NASDAQ:EXPO) Vs Other Business Process Outsourcing & Consulting Stocks

December 10, 2025

Let’s dig into the relative performance of Exponent (NASDAQ:EXPO) and its peers as we unravel the now-completed Q3 business process outsourcing & consulting earnings season.

Via StockStory

Topics Artificial Intelligence Economy

3 Low-Volatility Stocks with Warning Signs

December 05, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

3 Small-Cap Stocks We Steer Clear Of

November 23, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Topics Supply Chain

EchoStar, Lumen, Exponent, TD SYNNEX, and IBM Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official hinted at a potential interest rate cut in December. John Williams, president of the Federal...

Via StockStory

Topics Economy Stocks

1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm

November 21, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Reasons to Sell EXPO and 1 Stock to Buy Instead

November 16, 2025

Over the past six months, Exponent’s shares (currently trading at $69.95) have posted a disappointing 12.5% loss, well below the S&P 500’s 13% gain. This may have investors wondering how to approach...

Via StockStory

Topics Stocks

The 5 Most Interesting Analyst Questions From Exponent’s Q3 Earnings Call

November 06, 2025

Exponent’s third quarter performance was led by robust demand for its dispute-related consulting work, particularly in the energy, transportation, life sciences, and construction sectors. Management...

Via StockStory

Topics Artificial Intelligence Earnings

3 of Wall Street’s Favorite Stocks We Find Risky

November 02, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

EXPO Q3 Deep Dive: Diversified Demand and Dispute Consulting Drive Growth, AI and Hiring in Focus

October 31, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.6% year on year to $137.1 million. Its GAAP profit of $0.55 per...

Via StockStory

Topics Artificial Intelligence

Exponent (EXPO) Q3 2025 Earnings Call Transcript ↗

October 30, 2025

Exponent (EXPO) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Exponent’s (NASDAQ:EXPO) Q3: Strong Sales

October 30, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q3 CY2025, with sales up 17.6% year on year to $147.1 million. Its GAAP profit of $0.55 per share was 8.5%...

Via StockStory

What To Expect From Exponent’s (EXPO) Q3 Earnings

October 28, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) will be announcing earnings results this Thursday afternoon. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

3 Profitable Stocks We’re Skeptical Of

October 27, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing ↗

October 26, 2025

Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing

Via The Motley Fool

Topics Regulatory Compliance

1 High-Flying Stock to Target This Week and 2 We Ignore

October 08, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

Topics Emissions

1 Services Stock for Long-Term Investors and 2 That Underwhelm

September 24, 2025

Business services providers play a critical role for enterprises, assisting them with everything from new hardware integrations to consulting and marketing. Furthermore, the demand for their offerings...

Via StockStory

Topics Stocks

3 Small-Cap Stocks That Fall Short

September 16, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

1 Oversold Stock Ready to Bounce Back and 2 We Brush Off

August 22, 2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

Winners And Losers Of Q2: Exponent (NASDAQ:EXPO) Vs The Rest Of The Business Process Outsourcing & Consulting Stocks

August 19, 2025

Let’s dig into the relative performance of Exponent (NASDAQ:EXPO) and its peers as we unravel the now-completed Q2 business process outsourcing & consulting earnings season.

Via StockStory

Topics Artificial Intelligence Economy

2 Cash-Heavy Stocks Worth Investigating and 1 We Ignore

August 14, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

EXPO Q2 Deep Dive: Litigation Demand Offsets Flat Revenue, Margin Compression Persists

August 12, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) beat Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $132.9 million. On the other hand, next quarter’s revenue...

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks with Open Questions

August 04, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Exponent (EXPO) Q2 Revenue Rises 1% ↗

August 01, 2025

Via The Motley Fool

Topics Artificial Intelligence Product Recall

CDW, CRA, Crane NXT, Diebold Nixdorf, and Exponent Shares Are Falling, What You Need To Know

August 01, 2025

A number of stocks fell in the morning session after a surprisingly weak U.S. jobs report was released, fueling concerns about a slowing economy.

Via StockStory

Topics Artificial Intelligence Economy

Exponent’s (NASDAQ:EXPO) Q2: Beats On Revenue But Quarterly Revenue Guidance Slightly Misses Expectations

July 31, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.2% year on year to $142 million. On the other hand, next...

Via StockStory

Exponent Inc (NASDAQ:EXPO) Delivers Mixed Q2 2025 Results with EPS Beat and Revenue Miss, Market Reaction Neutral ↗

July 31, 2025

Exponent Inc (NASDAQ:EXPO) reported mixed Q2 2025 results, with EPS beating estimates but revenue slightly missing. Shares remained flat post-earnings, reflecting neutral investor sentiment. The...

Via Chartmill

Exponent Inc (NASDAQ:EXPO) Stands Out as a High-Quality Pick Under the Caviar Cruise Strategy ↗

July 31, 2025

Exponent Inc (EXPO) excels with high profitability, strong cash flow, and steady growth, making it a top pick for long-term quality investors under the Caviar Cruise strategy.

Via Chartmill

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.